FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiology, and concerns treating the patients with atrial fibrillation or flutter and observed thrombi in the atrial cavity before sinus rhythm restoration. For this purpose, Trombovasim in capsules is introduced in dosage 700 UN 3 times a day for 7 days with the conventional warfarin-based treatment. It is followed with the control transoesophageal echocardiography and in the absence of thrombi in the atrial cavity ensures to perform sinus rhythm restoration.
EFFECT: method provides lower by-effects and reduced treatment length due to thrombi lysis during specified empirically selected length of Trombovasim introduction.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING ATRIAL FIBRILLATION | 2020 |
|
RU2728715C1 |
METHOD FOR REDUCTION OF REGULAR FORM OF AURICULAR FLUTTERING | 2008 |
|
RU2381006C1 |
METHOD OF PREVENTING INCISIONAL ATRIAL FLUTTER DURING SURGICAL CORRECTION OF HEART VALVULAR DISEASE | 2007 |
|
RU2407461C2 |
METHOD FOR TREATING ATRIAL FLUTTER PAROXYSM PATIENTS | 2000 |
|
RU2189262C2 |
METHOD FOR PREDICTING LEFT ATRIAL APPENDAGE THROMBOSIS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | 2021 |
|
RU2781152C1 |
METHOD FOR SINUS RHYTHM RESTORATION IN ATRIAL FLUTTER TYPE 1 | 2010 |
|
RU2448698C2 |
METHOD FOR BLOCKING ATRIAL FLUTTER | 0 |
|
SU1683678A1 |
METHOD FOR TREATING THE CASES OF ATRIAL FLUTTER | 1999 |
|
RU2200035C2 |
METHOD FOR PREDICTION OF LEFT ATRIAL THROMBOSIS BEFORE CATHETER ABLATION OR CARDIOVERSION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION OR FLUTTER | 2023 |
|
RU2815147C1 |
METHOD FOR TREATING ATRIAL FIBRILLATION IN CASE OF MYOCARDIAL INFARCTION | 2005 |
|
RU2268713C1 |
Authors
Dates
2010-10-27—Published
2009-06-08—Filed